108 related articles for article (PubMed ID: 12706078)
1. Dual role of tumor suppressor p53 in regulation of DNA replication and oncogene E6-promoter activity of epidermodysplasia verruciformis-associated human papillomavirus type 8.
Akgül B; Karle P; Adam M; Fuchs PG; Pfister HJ
Virology; 2003 Apr; 308(2):279-90. PubMed ID: 12706078
[TBL] [Abstract][Full Text] [Related]
2. Genetic heterogeneity among human papillomaviruses (HPV) associated with epidermodysplasia verruciformis: evidence for multiple allelic forms of HPV5 and HPV8 E6 genes.
Deau MC; Favre M; Orth G
Virology; 1991 Oct; 184(2):492-503. PubMed ID: 1653484
[TBL] [Abstract][Full Text] [Related]
3. Late promoter of human papillomavirus type 8 and its regulation.
Stubenrauch F; Malejczyk J; Fuchs PG; Pfister H
J Virol; 1992 Jun; 66(6):3485-93. PubMed ID: 1316464
[TBL] [Abstract][Full Text] [Related]
4. Transcription Properties of Beta-HPV8 and HPV38 Genomes in Human Keratinocytes.
Rehm TM; Straub E; Forchhammer S; Leiter U; Iftner T; Stubenrauch F
J Virol; 2022 Dec; 96(23):e0149822. PubMed ID: 36394329
[TBL] [Abstract][Full Text] [Related]
5. Interferon regulatory factor 5.2 acts as a transcription repressor of Epidermodysplasia verruciformis-associated human papillomaviruses.
Akgül B; Cürten M; Haigis H; Rogosz I; Pfister H
Arch Virol; 2006 Dec; 151(12):2461-73. PubMed ID: 16773233
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional silencer of the human papillomavirus type 8 late promoter interacts alternatively with the viral trans activator E2 or with a cellular factor.
May M; Grassmann K; Pfister H; Fuchs PG
J Virol; 1994 Jun; 68(6):3612-9. PubMed ID: 8189499
[TBL] [Abstract][Full Text] [Related]
7. Interaction of human papillomavirus 8 regulatory proteins E2, E6 and E7 with components of the TFIID complex.
Enzenauer C; Mengus G; Lavigne A; Davidson I; Pfister H; May M
Intervirology; 1998; 41(2-3):80-90. PubMed ID: 9820841
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous HPV8 and MmuPV1 E6 Proteins Target the NOTCH and TGF-β Tumor Suppressors to Inhibit Differentiation and Sustain Keratinocyte Proliferation.
Meyers JM; Uberoi A; Grace M; Lambert PF; Munger K
PLoS Pathog; 2017 Jan; 13(1):e1006171. PubMed ID: 28107544
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression.
Hubert WG; Laimins LA
J Virol; 2002 Mar; 76(5):2263-73. PubMed ID: 11836404
[TBL] [Abstract][Full Text] [Related]
10. Identification of C/EBPα as a novel target of the HPV8 E6 protein regulating miR-203 in human keratinocytes.
Marthaler AM; Podgorska M; Feld P; Fingerle A; Knerr-Rupp K; Grässer F; Smola H; Roemer K; Ebert E; Kim YJ; Bohle RM; Müller CSL; Reichrath J; Vogt T; Malejczyk M; Majewski S; Smola S
PLoS Pathog; 2017 Jun; 13(6):e1006406. PubMed ID: 28640877
[TBL] [Abstract][Full Text] [Related]
11. Low-affinity E2-binding site mediates downmodulation of E2 transactivation of the human papillomavirus type 8 late promoter.
Stubenrauch F; Pfister H
J Virol; 1994 Nov; 68(11):6959-66. PubMed ID: 7933077
[TBL] [Abstract][Full Text] [Related]
12. Differences in transforming activity and coded amino acid sequence among E6 genes of several papillomaviruses associated with epidermodysplasia verruciformis.
Kiyono T; Hiraiwa A; Ishibashi M
Virology; 1992 Feb; 186(2):628-39. PubMed ID: 1310189
[TBL] [Abstract][Full Text] [Related]
13. The E6 protein of the cutaneous human papillomavirus type 8 can stimulate the viral early and late promoters by distinct mechanisms.
Müller-Schiffmann A; Beckmann J; Steger G
J Virol; 2006 Sep; 80(17):8718-28. PubMed ID: 16912319
[TBL] [Abstract][Full Text] [Related]
14. Regulatory interactions of transcription factor YY1 with control sequences of the E6 promoter of human papillomavirus type 8.
Pajunk HS; May C; Pfister H; Fuchs PG
J Gen Virol; 1997 Dec; 78 ( Pt 12)():3287-95. PubMed ID: 9400979
[TBL] [Abstract][Full Text] [Related]
15. DNA replication specificity and functional E2 interaction of the E1 proteins of human papillomavirus types 1a and 18 are determined by their carboxyl-terminal halves.
Gopalakrishnan V; Sheahan L; Khan SA
Virology; 1999 Apr; 256(2):330-9. PubMed ID: 10191198
[TBL] [Abstract][Full Text] [Related]
16. Unique topography of DNA-protein interactions in the non-coding region of epidermodysplasia verruciformis-associated human papillomaviruses.
May M; Helbl V; Pfister H; Fuchs PG
J Gen Virol; 1991 Dec; 72 ( Pt 12)():2989-97. PubMed ID: 1662691
[TBL] [Abstract][Full Text] [Related]
17. Differentiation-dependent transcription of the epidermodysplasia verruciformis-associated human papillomavirus type 5 in benign lesions.
Haller K; Stubenrauch F; Pfister H
Virology; 1995 Dec; 214(1):245-55. PubMed ID: 8525623
[TBL] [Abstract][Full Text] [Related]
18. In vitro expressed HPV 8 E6 protein does not bind p53.
Steger G; Pfister H
Arch Virol; 1992; 125(1-4):355-60. PubMed ID: 1642560
[TBL] [Abstract][Full Text] [Related]
19. E2 represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors.
Stubenrauch F; Leigh IM; Pfister H
J Virol; 1996 Jan; 70(1):119-26. PubMed ID: 8523515
[TBL] [Abstract][Full Text] [Related]
20. Identification of sequence requirement for the origin of DNA replication in human papillomavirus type 18.
Lee D; Kim H; Lee Y; Choe J
Virus Res; 1997 Nov; 52(1):97-108. PubMed ID: 9453148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
